MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Pfizer

Avatud

SektorTervishoid

27.59 3.1

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

26.63

Max

27.56

Põhinäitajad

By Trading Economics

Sissetulek

-45M

2.9B

Müük

938M

15B

P/E

Sektori keskmine

12.553

35.739

Aktsiakasum

0.51

Dividenditootlus

7.15

Kasumimarginaal

19.982

Töötajad

81,000

EBITDA

266M

5.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+4.85% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

7.15%

3.08%

Järgmine tulemuste avaldamine

4. nov 2025

Järgmine dividendimakse kuupäev

1. dets 2025

Järgmine aktsia dividendi kuupäev (ex-date)

7. nov 2025

Turustatistika

By TradingEconomics

Turukapital

1.8B

136B

Eelmine avamishind

24.49

Eelmine sulgemishind

27.59

Uudiste sentiment

By Acuity

46%

54%

140 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Pfizer Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. okt 2025, 08:54 UTC

Suurimad hinnamuutused turgudel

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30. sept 2025, 15:07 UTC

Suurimad hinnamuutused turgudel

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22. sept 2025, 14:54 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22. sept 2025, 11:51 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22. sept 2025, 11:09 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22. sept 2025, 10:13 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22. sept 2025, 07:42 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5. aug 2025, 11:34 UTC

Tulu

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22. sept 2025, 15:17 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22. sept 2025, 13:43 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22. sept 2025, 11:26 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22. sept 2025, 11:26 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22. sept 2025, 10:48 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22. sept 2025, 10:47 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22. sept 2025, 10:46 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22. sept 2025, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22. sept 2025, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22. sept 2025, 09:12 UTC

Kuumad aktsiad

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5. aug 2025, 20:44 UTC

Tulu

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5. aug 2025, 18:20 UTC

Tulu

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5. aug 2025, 18:17 UTC

Tulu

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5. aug 2025, 16:04 UTC

Market Talk

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5. aug 2025, 15:25 UTC

Tulu

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5. aug 2025, 13:56 UTC

Tulu

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5. aug 2025, 11:43 UTC

Tulu

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5. aug 2025, 11:27 UTC

Tulu

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5. aug 2025, 10:57 UTC

Tulu

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5. aug 2025, 10:55 UTC

Tulu

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5. aug 2025, 10:53 UTC

Tulu

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5. aug 2025, 10:51 UTC

Tulu

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Võrdlus sarnastega

Hinnamuutus

Pfizer Prognoos

Hinnasiht

By TipRanks

4.85% tõus

12 kuu keskmine prognoos

Keskmine 28.53 USD  4.85%

Kõrge 34 USD

Madal 24 USD

Põhineb 17 Wall Streeti analüütiku instrumendi Pfizer 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

17 ratings

4

Osta

12

Hoia

1

Müü

Tehniline skoor

By Trading Central

22.855 / 23.85Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

140 / 371 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat